Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00176241
Recruitment Status : Terminated (Slow accrual)
First Posted : September 15, 2005
Last Update Posted : June 8, 2015
Eli Lilly and Company
Information provided by (Responsible Party):
Susanne Arnold, University of Kentucky

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2008
  Actual Study Completion Date : November 2008